Recruiting
Phase 1

Vorinostat in Combination With Chemotherapy in Relapsed/Refractory Solid Tumors and CNS Malignancies

Sponsor:

New York Medical College

Code:

NCT04308330

Conditions

Ewing Sarcoma

Rhabdomyosarcoma

Wilms Tumor

Neuroblastoma

Hepatoblastoma

Eligibility Criteria

Sex: All

Age: 1 - 30

Healthy Volunteers: Not accepted

Interventions

Vorinostat

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information